| Mrs Georgia A Hetland, RPH | |
|
122 E Kemp, Watertown, SD 57201-3640 | |
| (605) 882-4809 | |
| Not Available |
| Full Name | Mrs Georgia A Hetland |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 122 E Kemp, Watertown, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548350986 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | R4350 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Georgia A Hetland, RPH 312 6th Ave Nw, Watertown, SD 57201-2346 Ph: (605) 882-2842 | Mrs Georgia A Hetland, RPH 122 E Kemp, Watertown, SD 57201-3640 Ph: (605) 882-4809 |
News Archive
Reuters on a report from the Organisation for Economic Cooperation and Development: The increase in health spending is "piling pressure budgets already hit" by the recession and is "likely to continue rising as populations age, technology improves and public expectations grow. ... Given the urgent need to reduce their budget deficits, many OECD governments will have to make difficult choices to sustain their healthcare systems: curb the growth of public spending on health, cut spending in other areas, or raise taxes," according to the report.
Medivir (STO:MVIRB) has deepened its presence, and expanded its commercial interest, in the therapeutic area of bone diseases by selecting a further candidate drug that targets the protease cathepsin K, a recognized drug target in this area. This builds on Medivir's existing interest in bone related disorders which includes already one candidate drug and positive phase I experience from MIV-701.
In the spring of 2017, 12,146 individuals with hypothyroidism responded to an online survey posted on a variety of websites and social media for two months by the Program Committee of the Satellite Symposium on Hypothyroidism, organized by the American Thyroid Association.
New research from Wake Forest Baptist Medical Center shows that a diabetes prevention program led by community health workers is effective at reducing blood glucose and potentially reducing diabetes over the long term.
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
› Verified 9 days ago
Deidra J Vangilder, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 506 1st Ave Se, Watertown, SD 57201 Phone: 605-886-8482 Fax: 605-884-4300 | |
Shannon Kraus, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1320 9th Ave Se, Watertown, SD 57201 Phone: 605-886-0661 | |
Liza Jensen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 123 19th St Ne, Watertown, SD 57201 Phone: 605-882-9400 | |
Ms. Carla R Fisher, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1320 9th Ave Se, Watertown, SD 57201 Phone: 605-886-0661 Fax: 605-886-0721 | |
Jessica Sittig, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 29th St Se, Watertown, SD 57201 Phone: 605-886-8419 | |
Kay Lynn Quale, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 123 19th St Ne, Watertown, SD 57201 Phone: 605-881-4532 | |
Denise Joy Spies, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 421 9th Ave Se, Watertown, SD 57201 Phone: 605-882-3788 |